Orvil is a 71-year-old prostate cancer survivor. He regularly had preventive exams, digital tests, and blood tests to screen for prostate cancer since age 50, and about ten years ago, tests revealed that his prostate was enlarged. Initially, the doctors…
No Vaccine, No Admittance?
Vaccine hesitancy has become a complex global problem. This hesitancy threatens to reverse progress made in tackling vaccine-preventable diseases. And as such, more doctors have implemented policies of dismissing families who refuse to vaccinate their children. Doctors who do decide…
Eating Disorders Awareness Week, 25th February – 3rd March
The week of February 25th to the 3rd March marks an important time within our calendars, for a reason that some may not initially be aware. It is Eating Disorders Awareness Week, the pivotal international event for raising awareness…
Effect of Violence on Healthcare
Deliberate, calculated attacks on healthcare facilities have become a routine weapon of war. These assaults kill both patients and health workers, and they devastate already vulnerable health systems. Not to mention they violate the Geneva Conventions. In 2017, there were…
Brexit and the delay in the supply of medicines
Earlier this year, the Brexit Health Alliance published a paper calling on both the UK and EU to put patients first. It warned that unless a deal can be reached, medicines and medical technologies could be delayed or, in extreme…
Technology investment in the healthcare sector
Our first monthly Pulse of 2018 asked the M3 Global Research community their opinions on technology investment in healthcare. The healthcare sector has experienced dramatic changes over the last 25 years and will likely continue to change and evolve in the immediate future. Technology is…
Take Part in a Melanoma Patient Outcome Study
Patient outcome studies are becoming increasingly important as they provide a truly in-depth analysis of the chosen subject matter as well as benefits to the participants. We are pleased to announce that we will have a patient outcome study regarding melanoma…